Mary Moreland - Abbott Laboratories Ex HR
| ABL Stock | EUR 111.12 3.04 2.81% |
Insider
Mary Moreland is Ex HR of Abbott Laboratories
| Age | 57 |
| Phone | 224 667 6100 |
| Web | https://www.abbott.com |
Abbott Laboratories Management Efficiency
The company has return on total asset (ROA) of 0.0738 % which means that it generated a profit of $0.0738 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1901 %, meaning that it generated $0.1901 on every $100 dollars invested by stockholders. Abbott Laboratories' management efficiency ratios could be used to measure how well Abbott Laboratories manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Julie Coletti | Align Technology | 54 | |
| Arnold Pinkston | Edwards Lifesciences | 64 | |
| Jason Beach | Stryker | N/A | |
| Alan Douville | Stryker | N/A | |
| Christian Klaussner | Siemens Healthineers AG | N/A | |
| Angela Wiczek | Insulet | N/A | |
| Zelko Relic | Align Technology | 58 | |
| Charles Alpuche | Insulet | 63 | |
| Joseph Hogan | Align Technology | 66 | |
| Jennifer OlsonWilk | Align Technology | 45 | |
| Elaine Leavenworth | Abbott Laboratories | 64 | |
| Jochen Schmitz | Siemens Healthineers AG | 57 | |
| Stuart Hockridge | Align Technology | 51 | |
| Shirley Stacy | Align Technology | N/A | |
| Simon Beard | Align Technology | 56 | |
| Mark Wilterding | Edwards Lifesciences | N/A | |
| Donald Bobo | Edwards Lifesciences | 61 | |
| Andre Hartung | Siemens Healthineers AG | N/A | |
| Michael Mahoney | Boston Scientific | 58 | |
| Christopher Toth | Siemens Healthineers AG | 44 | |
| Melissa Brotz | Abbott Laboratories | N/A | |
Management Performance
| Return On Equity | 0.19 | |||
| Return On Asset | 0.0738 |
Abbott Laboratories Leadership Team
Elected by the shareholders, the Abbott Laboratories' board of directors comprises two types of representatives: Abbott Laboratories inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Abbott. The board's role is to monitor Abbott Laboratories' management team and ensure that shareholders' interests are well served. Abbott Laboratories' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Abbott Laboratories' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Scott Leinenweber, Licensing Relations | ||
| Robert Ford, Pres Chairman | ||
| James Young, VP Officer | ||
| Elaine Leavenworth, VP Officer | ||
| Mary Moreland, Ex HR | ||
| Robert Funck, Exec CFO | ||
| Daniel Salvadori, Ex Products | ||
| Andrea Wainer, Ex Diagnostics | ||
| Hubert Allen, Gen VP | ||
| Melissa Brotz, VP Marketing |
Abbott Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Abbott Laboratories a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.19 | |||
| Return On Asset | 0.0738 | |||
| Profit Margin | 0.16 % | |||
| Operating Margin | 0.20 % | |||
| Current Valuation | 190.22 B | |||
| Shares Outstanding | 1.74 B | |||
| Shares Owned By Insiders | 0.70 % | |||
| Shares Owned By Institutions | 76.37 % | |||
| Price To Earning | 41.25 X | |||
| Price To Book | 5.40 X |
Currently Active Assets on Macroaxis
| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin | |
| ADA | Cardano | |
| XRP | XRP |
Additional Information and Resources on Investing in Abbott Stock
When determining whether Abbott Laboratories is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Abbott Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Abbott Laboratories Stock. Highlighted below are key reports to facilitate an investment decision about Abbott Laboratories Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abbott Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Abbott Stock please use our How to Invest in Abbott Laboratories guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.